arrow
Back
P

Philippe Gabríel Steg

université paris-cité and ap-hp and inserm

180H-index
2.1KPaper Count
19.8WCitation Count
Published Papers 886
Publication Date
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score
err2026-02-09
err0
errOAAI
errJoris Holtrop; Mari N Gynnild; Matthew Richards; Carl-Emil Lim; Mitja Lääperi; Salil V Deo; Håvard Dalen; Peter Ueda; Sanjay Rajagopalan; Małgorzata Chlabicz; Karol Kaminski; Ignacio Mahíllo-Fernández; Ingvild Saltvedt; Jean-Eudes Dazard; Hanne Ellekjær; Philippe Gabriel Steg; José Tuñón; Torbjørn Omland; Juha Sinisalo; John Munkhaugen; Tomas Jernberg; Deepak L Bhatt; Angela Wood; Frank L J Visseren; Steven H J Hageman; Jannick A N Dorresteijn; null
errShare
errSave
Cardiovascular Outcomes with Icosapent Ethyl by Burden of Standard Modifiable Cardiovascular Risk Factors in REDUCE-IT
err2026-02-02
err0
errOAAI
errRahul Aggarwal; Deepak L. Bhatt; Michael Miller; Christie M. Ballantyne; Eliot A. Brinton; Terry A. Jacobson; Steven B. Ketchum; Jean-Claude Tardif; Matthew J. Budoff; Gemma A. Figtree; Ph. Gabriel Steg
errShare
errSave
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT
err2026-01-16
err0
errOAAI
errMichael Szarek; Deepak L Bhatt; Michael Miller; Eliot A Brinton; Jean-Claude Tardif; Christie M Ballantyne; Steven B Ketchum; Mandeep R Mehra; Ph Gabriel Steg
errShare
errSave
Icosapent Ethyl Reduces CVD Risk in Cardiovascular-Kidney-Metabolic Syndrome: REDUCE-IT CKM
err2025-12-19
err0
errOAAI
errMichael Miller; Deepak L. Bhatt; Eliot A. Brinton; Terry A. Jacobson; Ph. Gabriel Steg; Steven B. Ketchum; Armando Lira Pineda; Jean-Claude Tardif; Christie M. Ballantyne
errShare
errSave
Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndrome
err2025-12-01
err1
PREAI
errKovacevic, Mila; Jones, Daniel A.; Thiele, Holger; Steg, P. Gabriel; Kunadian, Vijay
errShare
errSave
Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial
err2025-11-26
err0
errOAAI
errShahab Ghafghazi; Lynne Uhl; Brandon Herbert; Marnie Bertolet; John H. Alexander; Shaun G. Goodman; Jay Raval; Francois Roubille; Christopher B. Fordyce; Michael Goldfarb; Kevin Bainey; Pedro Beraldo de Andrade; Janek Senaratne; Arthur Bracey; Robert O. Roswell; Renato Lopes; Tabassome Simon; Gabriel Steg; Maria M. Brooks; Paul C. Hebert; Jeffrey L. Carson; Darrell J. Triulizi; MINT Trial Investigators
errShare
errSave
Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT
err2025-11-01
err0
errOAAI
errGurevitz, Chen; Bhatt, Deepak L.; Giugliano, Robert P.; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A.; Jacobson, Terry A.; Ketchum, Steven B.; Pineda, Armando Lira; Doyle, Ralph T.; Giugliano, Gabriella; Mason, R. Preston; Tardif, Jean-Claude; Martens, Fabrice M. A. C.; Ballantyne, Christie M.; Budoff, Matthew J.; Gibson, C. Michael
errShare
errSave
Profiles and outcomes of patients treated with oral anticoagulants for atrial fibrillation who experience bleeding events requiring hospitalization in France
err2025-11-01
err0
PREAI
errDanchin, Nicolas; Guitard-Dehoux, Dominique; Nee, Melanie; Belhassen, Manon; Hanon, Olivier; Mahe, Isabelle; Steg, Philippe Gabriel; Micallef, Claire Marant
errShare
errSave
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation
errJACC
IF0
err2025-09-01
err0
PREAI
errSean J. Jurgens; Giorgio E.M. Melloni; Shinwan Kany; Larissa Fabritz; Joel T. Rämö; Andreas Goette; Frederick K. Kamanu; David D. Berg; Christina Magnussen; Seung Hoan Choi; Marc P. Bonaca; Robert P. Giugliano; Benjamin M. Scirica; Stephen D. Wiviott; Deepak L. Bhatt; Philippe Gabriel Steg; Itamar Raz; Eugene Braunwald; James P. Pirruccello; Marc S. Sabatine; Nicholas A. Marston; Paulus Kirchhof; Patrick T. Ellinor; Christian T. Ruff
errShare
errSave
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events
errJACC
IF0
err2025-08-27
err0
PREAI
errKausik K. Ray; Michael Szarek; Deepak L. Bhatt; Vera A. Bittner; Sergio Fazio; Shaun G. Goodman; Robert A. Harrington; J. Wouter Jukema; Harvey D. White; Ph. Gabriel Steg; Gregory G. Schwartz
errShare
errSave
Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia
errHEART
IF4.4
err2025-05-10
err0
PREAI
errRoger, Guillaume; Packard, Chris J.; Masana, Luis; Laufs, Ulrich; Catapano, Alberico L.; Steg, Philippe Gabriel
errShare
errSave
Smoking trajectories and residual cardiovascular risk in patients with stable coronary artery disease: an international cohort study
err2025-05-01
err3
PREAI
errMesnier, Jules; Giovachini, Louis; Ducrocq, Gregory; Danchin, Nicolas; Ford, Ian; Tendera, Michal; Feldman, Laurent J.; Ferrari, Roberto; Tardif, Jean-Claude; Fox, Kim M.; Vidal-Petiot, Emmanuelle; Steg, Philippe Gabriel
errShare
errSave
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
err2025-04-16
err0
PREAI
errKAROLA S. JERING; BRIAN L. CLAGGETT; EUGENE BRAUNWALD; CHRISTOPHER B. GRANGER; LARS KØBER; ULF LANDMESSER; ELDRIN F. LEWIS; ALDO P. MAGGIONI; DOUGLAS L. MANN; JOHN JV MCMURRAY; ROXANA MEHRAN; MARK C. PETRIE; MARGARET F. PRESCOTT; JEAN L. ROULEAU; MORTEN SCHOU; SCOTT D SOLOMON; PHILIPPE GABRIEL STEG; DIRK VON LEWINSKI; MARC A. PFEFFER
errShare
errSave
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin
err2025-04-09
err0
PREAI
errRam D. Bhatt; Bertram Pitt; Ph. Gabriel Steg; Deepak L. Bhatt
errShare
errSave
Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapy
err2025-03-19
err0
errOAAI
errWang, Yishu; Courcelles, Eulalie; Peyronnet, Emmanuel; Porte, Solene; Diatchenko, Alizee; Jacob, Evgueni; Angoulvant, Denis; Amarenco, Pierre; Boccara, Franck; Cariou, Bertrand; Mahe, Guillaume; Steg, Philippe Gabriel; Bastien, Alexandre; Portal, Lolita; Boissel, Jean-Pierre; Granjeon-Noriot, Solene; Bechet, Emmanuelle
errShare
errSave
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial
err2025-02-19
err0
errOAAI
errAggarwal, Rahul; Bhatt, Deepak L.; Steg, Ph. Gabriel; Miller, Michael; Brinton, Eliot A.; Dunbar, Richard L.; Ketchum, Steven B.; Tardif, Jean-Claude; Martens, Fabrice M. A. C.; Ballantyne, Christie M.; Szarek, Michael; Mason, R. Preston; REDUCE IT Investigators
errShare
errSave
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial
err2025-02-06
err0
PREAI
errSchwartz, Gregory G.; Szarek, Michael; Jukema, J. Wouter; Cobbaert, Christa M.; Reijnders, Esther; Bittner, Vera A.; Schwertfeger, Markus; Bhatt, Deepak L.; Fazio, Sergio; Garon, Genevieve; Goodman, Shaun G.; Harrington, Robert A.; White, Harvey D.; Steg, Philippe Gabriel
errShare
errSave
REPLY: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial Interpret With Caution
err2025-02-01
err0
PREAI
errZahger, Doron; Schwartz, Gregory G.; Szarek, Michael; Fazio, Sergio; Steg, P. Gabriel
errShare
errSave